• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by High Tide Inc.

    6/17/26 7:50:30 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary
    Get the next $HITI alert in real time by email
    6-K 1 hightide6k.htm FORM 6-K High Tide Inc.: Form 6-K - Filed by newsfilecorp.com

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 6-K

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    OF THE SECURITIES EXCHANGE ACT OF 1934

    For the month of June 2026

    Commission File Number: 001-40258

    HIGH TIDE INC.

    (Registrant)

    11127 – 15 Street N.E., Unit 112

    Calgary, Alberta

    Canada T3K 2M4

    (Address of Principal Executive Offices)

     

    Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    Form 20-F  ☐            Form 40-F  ☒

     

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

     

     

     

     

     

     

     

     

     

     

     

    HIGH TIDE INC.

     

     

     

     

    (Registrant)

     

     

     

     

    Date: June 17, 2026

     

     

     

    By

     

    /s/ Raj Grover

     

     

     

     

     

     

    Raj Grover

     

     

     

     

     

     

    President and Chief Executive Officer

     

     

     

     

     

     

     

     

     

    EXHIBIT INDEX

         

    Exhibit

       Description of Exhibit
       
    99.1   News Release dated June 17, 2026

    Get the next $HITI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HITI

    DatePrice TargetRatingAnalyst
    2/22/2022$7.75 → $7.25Neutral
    Cantor Fitzgerald
    12/10/2021$8.75 → $7.75Neutral
    Cantor Fitzgerald
    11/23/2021Neutral
    Cantor Fitzgerald
    11/23/2021$8.75Neutral
    Cantor Fitzgerald
    9/13/2021$12.00Buy
    ROTH Capital
    9/3/2021Buy
    Desjardins
    9/3/2021$15.00Buy
    Desjardins
    More analyst ratings

    $HITI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

    CALGARY, AB, June 17, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its majority-owned subsidiary, Remexian Pharma GmbH ("Remexian"), showcased its exclusive German medical cannabis distribution partnerships with leading Canadian cannabis brands at Mary Jane Berlin 2026, one of Europe's largest cannabis trade shows, held June 11–14, 2026, in Berlin, Germany. Through these partnerships, Remexian is bringing premium Canadian medical cannabis products to German patients and pharmacies, further strengthening its

    6/17/26 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

    The Company Also Reports Positive Free Cash Flow and Net IncomeThe Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive GrowthCanadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous YearELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,1 and Continues to Hold a Leading 12% Share of the Cannabis

    6/15/26 4:00:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Secures Credit Approval for C$40MM of Senior Secured Credit Facilities

    CALGARY, AB, June 15, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today announced that, further to its press release dated May 5, 2026, it has secured credit approval for a loan agreement (the "Loan Agreement") with Bank of Montreal ("BMO") in respect of new senior secured credit facilities in the principal amount of C$40 million (the "New Credit Facilities"). Closing of the New Credit Facilities remains subject to the satisfaction of customary closing conditions. Upon closing, the New Credit Facilities will replace the

    6/15/26 6:15:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    SEC Filings

    View All

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    6/17/26 7:50:30 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    6/15/26 4:46:21 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    6/15/26 4:03:10 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald reiterated coverage on High Tide with a new price target

    Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.25 from $7.75 previously

    2/22/22 6:03:19 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Cantor Fitzgerald reiterated coverage on High Tide with a new price target

    Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.75 from $8.75 previously

    12/10/21 5:41:48 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Cantor Fitzgerald initiated coverage on High Tide

    Cantor Fitzgerald initiated coverage of High Tide with a rating of Neutral

    11/23/21 7:32:46 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    Financials

    Live finance-specific insights

    View All

    High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

    The Company Also Reports Positive Free Cash Flow and Net IncomeThe Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive GrowthCanadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous YearELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,1 and Continues to Hold a Leading 12% Share of the Cannabis

    6/15/26 4:00:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Reports First Quarter 2026 Financial Results Featuring Record Revenue Exceeding $700 Million Annualized

    Canna Cabana Remains the Largest Cannabis Retailer in Canada with 220 Current Locations The Company Reiterates its Long-Term Goal to Exceed 350 Locations Across CanadaThe Company Generated $2.9 Million in Free Cash Flow During the Quarter, Marking Significant Improvements Year Over Year and Sequentially. Over the Past 12 Months, the Company Has Generated $16.8 Million in Free Cash FlowCanadian Cabana Club Members Now Exceed 2.58 Million, Up 47% Year Over Year, Marking the Fastest Pace in 10 Quarters and Remains the Largest Cannabis Loyalty Program GloballyELITE Members in Canada Have Surpassed 162,000, Up 100% Year Over YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Re

    3/17/26 4:00:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Reports Fourth Quarter and 2025 Year End Financial Results Featuring Record Revenue and Adjusted EBITDA

    The Company remains FCF positive for the fiscal year, while delivering strong same-store sales growth and cementing its presence within the German medical cannabis market Canadian Cabana Club Members Now Exceed 2.5 Million, Up 45% Year Over Year, Marking the Fastest Pace in Four Quarters ELITE Members in Canada Have Surpassed 151,000, Once Again Growing at the Fastest Rate Since Inception In Fiscal 2025, Same-Store Sales Were Up 4.1%. For the Fourth Fiscal Quarter, Same-Store Sales Rose 5.5% Year Over YearThe Company Opened 27 New Canna Cabana Locations Organically in Calendar 2025, Achieving the Higher End of Its Communicated Goal, and Remains the Largest Cannabis Retailer in Canada with 21

    1/29/26 4:01:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    Leadership Updates

    Live Leadership Updates

    View All

    High Tide and NuLeaf Naturals Join U.S. National Compassionate Care Council as Founding Members

    CALGARY, AB, March 4, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, and its leading U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, today announced they have joined the National Compassionate Care Council (NCCC) as founding members. "Federal cannabis policy in the United States is entering a meaningful transition," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Through our experience building

    3/4/26 10:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Announces Appointment of Two New Directors, and Appointment of Two Advisors with Focus on Real Estate and Artificial Intelligence

    CALGARY, AB, March 3, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today changes to its Board of Directors (the "Board") as part of a planned board renewal process. Board TransitionsThe Company announces that Nitin Kaushal and Andrea Elliott have resigned from the Board, effective March 2, 2026. On behalf of the Board and management, the Company thanks Mr. Kaushal, on the board since 2018, and Ms. Elliott,

    3/3/26 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH

    Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase

    8/14/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary